Anthrax |
|
|
For other uses, see Anthrax (disambiguation). Anthrax, also referred to as splenic fever, is an acute infectious disease caused by the bacteria Bacillus anthracis and is highly lethal in some forms. Anthrax most commonly occurs in wild and domestic herbivores, but it can also occur in humans when they are exposed to infected animals, tissue from infected animals, or high concentrations of anthrax spores. There are no known cases of infection in humans resulting from direct contact with a ...
Wikipedia - [full article]
Anthrax Clinical Trials
- Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed
ClinicalTrials.gov Identifier: NCT00170469 - Active, not recruiting
Bacillus Anthracis (Anthrax)
- Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients
ClinicalTrials.gov Identifier: NCT00050310 - Recruiting
Anthrax
- VHA Clinicians and Bioterror Events: Interactive Web-Based Learning
ClinicalTrials.gov Identifier: NCT00123396 - Active, not recruiting
Smallpox; Anthrax
- Safety Study of Anthrax Immune Globulin Derived From Human Serum
ClinicalTrials.gov Identifier: NCT00448253 - Recruiting
Symptoms of Inhalational Anthrax
- CDC Anthrax Vaccine Clinical Trial
ClinicalTrials.gov Identifier: NCT00119067 - Active, not recruiting
Healthy
- Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
ClinicalTrials.gov Identifier: NCT00031291 - Completed
Anthrax
- rPA (Anthrax)
ClinicalTrials.gov Identifier: NCT00063843 - Completed
Anthrax
- Monoclonal Antibody for Treatment of Inhalation Anthrax
ClinicalTrials.gov Identifier: NCT00138411 - Completed
Bacillus anthracis (anthrax)
- A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults
ClinicalTrials.gov Identifier: NCT00057525 - Completed
Anthrax
- Phase II Study of Range and Schedule of rPA Doses
ClinicalTrials.gov Identifier: NCT00170456 - Active, not recruiting
Bacillus Anthracis (Anthrax)
- Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine
ClinicalTrials.gov Identifier: NCT00103467 - Completed
Prevention of anthrax infection
- Anthrax Vaccine Clinical Trials
ClinicalTrials.gov Identifier: NCT00114621 - Recruiting
- Trial of rPA-102 Vaccine in Healthy Adult Volunteers
ClinicalTrials.gov Identifier: NCT00100724 - Completed
Anthrax
- UMD rPA Regimen Trial
ClinicalTrials.gov Identifier: NCT00133484 - Terminated
Bacillus anthracis (anthrax)

Not Signed In -


